Torrent Pharmaceuticals Ltd, the Ahmedabad based Rs 1033 crore pharmaceutical company, has received an approval status from the United States Food & Drug Agency (US FDA) for its API and formulations manufacturing facilities (excluding the parenteral facility) located at Chhatral, about 40 kms from Ahmedabad, a company press release stated.

Consequent to this, the company now expects approval of various ANDAs & DMFs (product dossiers for generic drug products & related APIs) it has submitted to the Agency. This will pave way for entry into the US market which is biggest generic drugs market in the world, the release added.

Currently, the company has submitted 3 DMFs and 5 ANDAs to the US FDA for approval. It has a development pipeline of 5 DMFs and 26 ANDAs.